Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 19, 2005 Stephen D. Simpson	ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note.
The Motley Fool January 31, 2006 Stephen D. Simpson	Guidance Puts ICU Medical in the Trauma Ward This oft-volatile stock had a strong fourth quarter, but weak guidance. Even with today's steep drop in price, the shares aren't cheap enough to be interesting.
The Motley Fool November 10, 2005 Stephen D. Simpson	Hospitable Treatment for Hospira Solid margins fuel strong earnings at the hybrid generics - medical distributor. Buying this stock wisely may be the key to good long-term returns.
The Motley Fool May 9, 2006 Stephen D. Simpson	Riding the Hospira Yo-Yo There's a solid foundation on this roller coaster pharmaceutical and drug delivery company. Maybe Hospira's current valuation doesn't make it a "gem," but that's not really within its control.
The Motley Fool August 10, 2006 Stephen D. Simpson	Volatility, Thy Name Is Hospira Margins continue to stand in the way of consistent performance at the health-care company. Investors, take note.
The Motley Fool July 19, 2005 Stephen D. Simpson	Peek-a-Boo ICU ICU Medical has taken on quite a bit of risk in the process of remaking the company. It's best to wait for a reasonable valuation before buying shares.
The Motley Fool May 4, 2006 Stephen D. Simpson	Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility.
The Motley Fool July 22, 2005 Stephen D. Simpson	Bio-Tech's Robot-Coaster Ride Intuitive Surgical is a high-growth, high-opportunity stock with a history of earnings-related volatility.
The Motley Fool July 27, 2006 Stephen D. Simpson	Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space.
The Motley Fool December 10, 2010 Sean Williams	ICU Medical: Bargain or Value Trap? International sales growth will be the key to the medical supplier's long-term success.
The Motley Fool July 26, 2006 Stephen D. Simpson	Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow.
The Motley Fool April 28, 2006 Stephen D. Simpson	Of Intuition and Intuitive Surgical Price has decoupled from value, but the company is growing like a weed. Investors, take note.
The Motley Fool April 27, 2005 Stephen D. Simpson	Becton, Dickinson's Boring Reliability This broadly diversified medical device company doesn't grow fast, but it is consistent. Investors looking for a stable and dependable company with broad exposure to the medical industry should take a look for themselves at Becton, Dickinson.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool July 3, 2006 Stephen D. Simpson	Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note.
The Motley Fool February 3, 2006 Stephen D. Simpson	Phase 2 for Intuitive Surgical Now that the initial rush is over, it's time for Intuitive Surgical to build a lasting business. Investors need to be careful with this one.
The Motley Fool October 31, 2005 Stephen D. Simpson	Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so.
The Motley Fool November 3, 2005 Stephen D. Simpson	Becton, Dickinson: More Boring Growth This company may seem to be just a collection of boring businesses making things like syringes, reagents, and safety products. But shareholders aren't feeling too bored with today's strong stock performance.
The Motley Fool July 27, 2005 Stephen D. Simpson	Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note.
The Motley Fool November 1, 2005 Stephen D. Simpson	Defense the Best Offense at Oshkosh Returns on capital have improved, but the quarter-to-quarter volatility is a cause for concern at this specialized truck manufacturer.
The Motley Fool October 20, 2005 Stephen D. Simpson	Baxter Needs Growth Infusion This is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go. Trading at nearly 20 times forward earnings, it seems like expectations of a growth revival are already in the stock.
The Motley Fool May 13, 2005 Brian Gorman	Hospira's Hopeful Signs The medical products company's strong quarter belies a less exciting future. Investors should probably take a wait-and-see attitude.
The Motley Fool October 31, 2008 Karl Thiel	Want the Highest Growth? One way investors try to identify opportunities is by chasing beta, the measure of an asset's volatility against a broader index. The basic idea is to buy high-beta stocks when you expect the market to start rising.
The Motley Fool July 25, 2007 Billy Fisher	Dueling Fools: Intuitive Surgical Bull For a company consistently growing its sales by 50% and maintaining healthy product margins, it's hard to imagine that this medical device maker's stock has yet met its peak.
The Motley Fool January 30, 2006 Stephen D. Simpson	Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea.
The Motley Fool May 9, 2005 Stephen D. Simpson	Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point.
The Motley Fool September 27, 2007 Billy Fisher	Baxter Looking to Bounce Back Shares of the medical device maker finally rebound following a company recall of infusion pumps.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool January 13, 2012 Dan Caplinger	Has Intuitive Surgical Become the Perfect Stock? What Intuitive Surgical needs to do to get even closer to perfection is to get to the point in its growth curve at which it's ready to start paying dividends.
The Motley Fool February 12, 2010 Brad Hessel	So Far, It's Not Like the 1930s Stock market volatility declines -- again.
BusinessWeek July 24, 2006 Jane Sasseen	Ta-Da! Cheaper Stock Options! Companies are tinkering with the formulas they use to value them.
Financial Planning February 1, 2012	Demystifying Volatility Investors shell-shocked by a recent period of extreme volatility may focus on avoiding exposure to volatility at all costs. However, those using the rear-view mirror to reduce volatility may risk long-term underperformance.
BusinessWeek May 31, 2004 Robert Barker	Hospira Just May Put You In The Pink If the Abbott Laboratories spin-off's first steps hardly seem promising, that's one reason why I see the company as worth much more of the intelligent investor's attention than the long calendar of pending tech and biotech IPOs.
The Motley Fool November 22, 2005 Stephen D. Simpson	Cyberonics' Ride Not Over Yet One way or another, this medical device maker's stock is almost certain to produce more volatility in the years to come.
The Motley Fool January 26, 2006 Stephen D. Simpson	Little Bits Add Up at Becton Dickinson Nothing flashy here, but consistent performance has delivered exceptional value for this health care and medical technology company. This stock has been nearly a 46-bagger over the past 20 years.
The Motley Fool August 2, 2005 Stephen D. Simpson	Fresh Del Monte: Rotten or Ripe? Patient shareholders might find sweet rewards here.
The Motley Fool January 13, 2012 Morgan Housel	Our Wild Market Is Much More Normal Than You Think Same problem, different year.
The Motley Fool May 25, 2011 Eben Esterhuizen	Value Ideas: Highly Profitable Stocks, Undervalued Relative to Revenue Growth Which of these names are you most bullish on?
The Motley Fool April 20, 2006 Stephen D. Simpson	Baxter Bags Better Margins This is a great business -- but only at the right price. Investors, this story has to be bought cheap. At today's prices, is it cheap enough?
Finance & Development December 2011 Arezki et al.	Less Volatile than Meets the Eye Contrary to popular wisdom, commodity prices can be more stable than those of manufactured products
The Motley Fool November 5, 2007 Brian Orelli	Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson.
The Motley Fool July 27, 2007 Brian Orelli	Stability From a Likely Source Becton Dickinson's earnings are solid. The medical device and lab supply company has reported growth in earnings and increases in margins.
The Motley Fool July 20, 2007 Brian Orelli	Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports.
The Motley Fool July 31, 2006 Stephen D. Simpson	Kinetic Concepts Approaches a Binary Outcome The resolution of a patent infringement trial means far more than one quarter's results for this med-tech company. Investors, take note.
The Motley Fool December 1, 2010 Anand Chokkavelu	This "Risky" Stock Isn't That Risky The market is serving up a tasty opportunity.
The Motley Fool May 5, 2006 Stephen D. Simpson	FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock.
The Motley Fool May 8, 2006 Stephen D. Simpson	A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company.
The Motley Fool April 3, 2007 Selena Maranjian	Meet the Fear Index The Chicago Board Options Exchange Volatility Index, also known as the VIX, is one way investors measure how volatile they expect the markets to be in the near future.
The Motley Fool February 12, 2004 Jeff Hwang	Rockin' Medtronic The world's premier medical device maker keeps on growing.
The Motley Fool October 13, 2010 Seth Jayson	From Gross to Net at Becton Dickinson With recent margins exceeding historical averages, medical device company Becton Dickinson looks like it's doing fine.